Wishing you all the joys of the season! 
Europe Rapid Test Kit Market Forecast to 2030
Europe Rapid Test Kit Market Forecast to 2030 – Regional Analysis – by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market
Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.
In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women’s and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.
In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.
In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.
In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.
In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.
Europe Rapid Test Kit Market Overview
The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.
Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)
Europe Rapid Test Kit Market Segmentation
The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.
In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.
By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.
Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.
In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.
Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. Increasing preference for PCR techniques and strategic initiatives by manufacturers are among the critical factors attributed to the Europe rapid test kit market expansion.
In recent years, molecular methods such as PCR have evolved as more effective diagnostic tools, as they aid in the precise diagnosis of a wide range of infectious diseases. Most of the popular molecular tests use reverse transcription polymerase chain reaction (RT-PCR). The technique provides reproducible results that are comparable between different laboratories and hence are accepted worldwide. The manufacturers are involved in new PCR developments.
For instance, GeneSoC is a recently developed system in which the PCR reaction solutions are reciprocally driven over numerous preheated zones and encapsulated on a chip within an extremely thin flow channel. GeneSoC is available for multiplex real-time PCR and is capable of concurrently detecting 3 fluorescence channels. It is regarded as an excellent alternative diagnostic technology for the detection of influenza A and B viruses, as it completes the real-time RT-PCR reaction in ~16 minutes. Further, the application of PCR technologies is also increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to the simple, rapid, and highly specific screening enabled by this tool. Thus, the growing preference for PCR as a diagnostic and clinical tool is expected to provide lucrative opportunities to the rapid test kits market during the forecast period.
On the contrary, uncertainties related to accuracy of results hamper the growth of Europe rapid test kit market.
Based on type, the Europe rapid test kit market is categorized into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held 62.7% market share in 2022, amassing US$ 3,286.09 million. It is projected to garner US$ 5,162.79 million by 2030 to register 5.8% CAGR during 2022-2030.
In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held 61.2% share of Europe rapid test kit market in 2022, amassing US$ 3,210.67 million. It is projected to garner US$ 4,918.78 million by 2030 to expand at 5.5% CAGR during 2022-2030.
By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held 44.2% share of Europe rapid test kit market in 2022, amassing US$ 2,319.46 million. It is projected to garner US$ 3,557.14 million by 2030 to expand at 5.5% CAGR during 2022-2030.
In terms of application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held 54.3% share of Europe rapid test kit market in 2022, amassing US$ 2,848.50 million. It is projected to garner US$ 4,369.80 million by 2030 to expand at 5.5% CAGR during 2022-2030.
By end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held 47.2% share of Europe rapid test kit market in 2022, amassing US$ 2,475.67 million. It is projected to garner US$ 3,653.75 million by 2030 to expand at 5.0% CAGR during 2022-2030.
Based on country, the Europe rapid test kit market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe rapid test kit market in 2022. It was assessed at US$ 1,389.86 million in 2022 and is likely to hit US$ 2,085.38 million by 2030, exhibiting a CAGR of 5.2% during 2022-2030.
Key players operating in the Europe rapid test kit market are F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc, among others.
In August 2022, Wondfo has partnered with MedAccess, the Clinton Health Access Initiative, and the WHO to make its HIV self-test available for US$1 in low- and middle-income regions. The partnership aims to improve HIV testing and global AIDS control, as 1/5 carriers are undiagnosed. The HIV Self-Test, which uses immunochromatography, offers quick results and is suitable for at-home testing and monitoring.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe rapid test kit market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Rapid Test Kits Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market – Europe Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
6. Europe Rapid Test Kits Market Analysis – by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Rapid Test Kits Market Analysis – by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Rapid Test Kits Market Analysis – by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Rapid Test Kits Market Analysis – by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Rapid Test Kits Market Analysis – by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe Rapid Test Kits Market – Country Analysis
11.1 Europe
11.1.1 Europe: Rapid Test Kits Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.2 Germany: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 United Kingdom
11.1.1.3.1 Overview
11.1.1.4 United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 France
11.1.1.5.1 Overview
11.1.1.6 France: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
11.1.1.7 Italy
11.1.1.7.1 Overview
11.1.1.8 Italy: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
11.1.1.9 Spain
11.1.1.9.1 Overview
11.1.1.10 Spain: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
11.1.1.11 Rest of Europe
11.1.1.11.1 Overview
11.1.1.12 Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Partec GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Fujirebio Europe NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cepheid
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Meril Life Sciences Pvt Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN NV
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OraSure Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Guangzhou Wondfo Biotech Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Denka Co Ltd
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Abbott Laboratories
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Trinity Biotech Plc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Premier Medical Corp Pvt Ltd
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Beckman Coulter Inc
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 4. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 5. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 6. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 7. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 8. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 9. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 10. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 11. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 12. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 13. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 14. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 16. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 17. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 18. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 19. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 20. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 21. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 22. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 23. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 24. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 25. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 26. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 28. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 30. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 31. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 32. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 33. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 34. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 35. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 36. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 37. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 38. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Rapid Test Kits Market Share (%) – by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) – by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) – by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) – by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) – by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Germany: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. United Kingdom: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. France: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. Italy: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Spain: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of Europe: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in the Rapid Test Kit Market
The List of Companies – Europe Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. Sysmex Partec GmbH
4. ARKRAY Inc
5. Fujirebio Europe NV
6. bioMerieux SA
7. Cepheid
8. Meril Life Sciences Pvt Ltd
9. QIAGEN NV
10. OraSure Technologies Inc
11. Guangzhou Wondfo Biotech Co Ltd
12. Denka Co Ltd
13. Abbott Laboratories
14. Trinity Biotech Plc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. Premier Medical Corp Pvt Ltd
18. DiaSorin SpA
19. Beckman Coulter Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.